WGRX vs. NEUP

Last updated Apr 1, 2026

Compare and contrast key facts about Wellgistics Health, Inc (WGRX) and Neuphoria Therapeutics Inc (NEUP).

Performance

WGRX vs. NEUP - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Wellgistics Health, Inc (WGRX) and Neuphoria Therapeutics Inc (NEUP). The values are adjusted to include any dividend payments, if applicable.

WGRX vs. NEUP - Yearly Performance Comparison

	2026 (YTD)	2025
WGRX Wellgistics Health, Inc	-75.87%	-89.51%
NEUP Neuphoria Therapeutics Inc	4.90%	-20.49%

Fundamentals

Market Cap WGRX : $6.84M NEUP : $18.46M
EPS WGRX : -$1.47 NEUP : -$133.25
PS Ratio WGRX : 0.29 NEUP : 1.39
Total Revenue (TTM) WGRX : $23.34M NEUP : $8.21M
Gross Profit (TTM) WGRX : -$6.43M NEUP : $8.03M
EBITDA (TTM) WGRX : -$90.54M NEUP : -$847.60M

Returns By Period

In the year-to-date period, WGRX achieves a -75.87% return, which is significantly lower than NEUP's 4.90% return.

WGRX

• 1D: -3.60%
• 1M: -59.67%
• YTD: -75.87%
• 6M: -89.13%
• 1Y: -97.77%
• 3Y*: —
• 5Y*: —
• 10Y*: —

NEUP

• 1D: 3.30%
• 1M: -1.93%
• YTD: 4.90%
• 6M: -65.48%
• 1Y: -29.34%
• 3Y*: —
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

WGRX vs. NEUP — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

WGRX

WGRX Risk / Return Rank: 11
WGRX Sharpe Ratio Rank: 23
WGRX Sortino Ratio Rank: 4
WGRX Omega Ratio Rank: 8
WGRX Calmar Ratio Rank: 1
WGRX Martin Ratio Rank: 17

NEUP

NEUP Risk / Return Rank: 39
NEUP Sharpe Ratio Rank: 30
NEUP Sortino Ratio Rank: 47
NEUP Omega Ratio Rank: 54
NEUP Calmar Ratio Rank: 30
NEUP Martin Ratio Rank: 32

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

WGRX vs. NEUP - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Wellgistics Health, Inc (WGRX) and Neuphoria Therapeutics Inc (NEUP). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	WGRX	NEUP	Difference
Sharpe ratio Return per unit of total volatility	-0.40	-0.23	-0.16
Sortino ratio Return per unit of downside risk	-1.63	0.72	-2.35
Omega ratio Gain probability vs. loss probability	0.83	1.13	-0.30
Calmar ratio Return relative to maximum drawdown	-1.00	-0.35	-0.64
Martin ratio Return relative to average drawdown	-1.24	-0.54	-0.70
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

WGRX vs. NEUP - Sharpe Ratio Comparison

The current WGRX Sharpe Ratio is -0.40, which is lower than the NEUP Sharpe Ratio of -0.23. The chart below compares the historical Sharpe Ratios of WGRX and NEUP, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	WGRX	NEUP	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	-0.40	-0.23	-0.16
Sharpe Ratio (All Time) Calculated using the full available price history	-0.40	-0.45	+0.05

Correlation

The correlation between WGRX and NEUP is 0.12, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

WGRX vs. NEUP - Dividend Comparison

Neither WGRX nor NEUP has paid dividends to shareholders.

Tickers have no history of dividend payments

Drawdowns

WGRX vs. NEUP - Drawdown Comparison

The maximum WGRX drawdown since its inception was -98.06%, roughly equal to the maximum NEUP drawdown of -96.32%. Use the drawdown chart below to compare losses from any high point for WGRX and NEUP.

Drawdown Indicators

	WGRX	NEUP	Difference
Max Drawdown Largest peak-to-trough decline	-98.06%	-96.32%	-1.74%
Max Drawdown (1Y) Largest decline over 1 year	-97.89%	-81.40%	-16.49%
Current Drawdown Current decline from peak	-98.06%	-94.88%	-3.18%
Average Drawdown Average peak-to-trough decline	-71.18%	-91.68%	+20.50%
Ulcer Index Depth and duration of drawdowns from previous peaks	78.38%	53.00%	+25.38%

Volatility

WGRX vs. NEUP - Volatility Comparison

Wellgistics Health, Inc (WGRX) has a higher volatility of 36.72% compared to Neuphoria Therapeutics Inc (NEUP) at 15.42%. This indicates that WGRX's price experiences larger fluctuations and is considered to be riskier than NEUP based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	WGRX	NEUP	Difference
Volatility (1M) Calculated over the trailing 1-month period	36.72%	15.42%	+21.30%
Volatility (6M) Calculated over the trailing 6-month period	138.08%	138.86%	-0.78%
Volatility (1Y) Calculated over the trailing 1-year period	246.39%	125.70%	+120.69%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	239.98%	182.50%	+57.48%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	239.98%	182.50%	+57.48%

Financials